SGLT2 inhibitors: uncovering the mechanisms of cardiovascular risk reduction
2 September 2019 (13:25 - 13:40)
Organised by:
Slides
About the speaker
St. Michael's Hospital, Toronto (Canada)
4 More presentations in this session
Doctor M. Bonaca (Aurora, US)
Doctor M. Kosiborod (Kansas City, US)
Professor F. Ruschitzka (Zurich, CH)
Doctor M. Bonaca (Aurora, US)
Professor S. Verma (Toronto, CA)
Doctor M. Kosiborod (Kansas City, US)
Access the full session
The Event
ESC Congress 2019
2 September 2019
13:25 CET
You may be interested in
Congress Session
